Editas Medicine (NASDAQ: EDIT) reported Q4 EPS of ($1.00), versus ($0.74) reported last year. Revenue for the quarter came in at $11.4 million, versus $12.3 million reported last year.

For earnings history and earnings-related data on Editas Medicine (EDIT) click here.